AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA, Inc., 583 F.3d 766, CPLRG 0005 (Fed. Cir. 2009) astrazenecateva09252009
MAJOR ISSUES: inequitable conduct, no intent to deceive, disclosure of comparative data as requested by examiner to overcome obviousness rejection, failure to disclose internal data on other related compounds, failure to synthesize compounds for comparative testing
Avid Identification Systems, Inc. v. Crystal Import Corp., 603 F.3d 967, CPLRG 0059 (Fed. Cir. 2010) (PROST & Mayer; LINN, concurring-in-part & dissenting-in-part)AvidIdentification04272010
MAJOR ISSUES: inequitable conduct; individuals subject to duty of candor; person other than inventors, attorneys and agents; substantive involvement in preparation or prosecution of patent application Read CPLRG™ 0059
Bid for Position, LLC v. AOL, LLC, 601 F.3d 1311 (Fed. Cir. 2010) (BRYSON, Newman & Moore)BidforPosition04072010
MAJOR ISSUES: prosecution history disclaimer; doctrine of equivalents Read CPLRG™ 0045
Bilski v. Kappos, 130 S. Ct. 3218, CPLRG 0015 (2010) (KENNEDY, Roberts, Thomas, Alito & Scalia (except for Parts II-B-2 and II-C-2), STEVENS, Ginsburg, Breyer & Sotomayor, concurring; BREYER & Scalia (as to Part II), concurring)
MAJOR ISSUES: Business method patents; “process” in Section 101; exceptions for abstract ideas, natural phenomena, and laws of nature Read CPLRG™ 0015
Board of Trustees of the Leland Stanford Junior Univ. v. Roche Molecular Sys., 131 S. Ct. 2188 (June 6, 2011) (ROBERTS, Scalia, Kennedy, Thomas, Alito & Kagan; SOTOMAYOR, concurring; BREYER & Ginsburg, dissenting) StanfordUniversityv.RocheMolecular06062011
MAJOR ISSUES: ownership of inventions and patent rights; initial ownership vesting in inventor; employee inventions; federally-funded inventions; universities as federal contractors
“Since 1790, the patent law has operated on the premise that rights in an invention belong to the inventor.” Read CPLRG™ 0070
